Retinal Vessel Abnormalities Are Associated with Elevated Fasting Insulin Levels and Cerebral Atrophy in Nondiabetic Individuals

Ophthalmology

Volumn 116, Issue 6, 2009, Pages 1175-1181

  Tirsi, Aziz ^a   Bruehl, Hannah ^a   Sweat, Victoria ^a   Tsui, Wai ^a,b   Reddy, Shantan ^a   Javier, Elizabeth ^a   Lee, Carol ^a   Convit, Antonio ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AGED; ARTICLE; BRAIN ATROPHY; CAMERA; CLINICAL ARTICLE; CONGENITAL BLOOD VESSEL MALFORMATION; CONTROLLED STUDY; DATA ANALYSIS; DIABETES MELLITUS; DIGITAL IMAGING; DISEASE ASSOCIATION; FEMALE; GLUCOSE TOLERANCE; HOMEOSTASIS; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC DISK; PHOTOGRAPHY; PRIORITY JOURNAL; RETINA BLOOD VESSEL;

ADULT; AGED; ATROPHY; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; BRAIN; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; FIBRINOGEN; HUMANS; HYPERINSULINISM; HYPERTENSION; INSULIN; INSULIN RESISTANCE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PHOTOGRAPHY; RETINAL VESSELS;

EID: 67349189131     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2008.12.046     Document Type: Article

References (48)

1. Patton N., Aslam T., MacGillivray T., et al. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J Anat 206 (2005) 319-348
2. Wong T.Y., Klein R., Sharrett A.R., et al., Atherosclerosis Risk in Communities Study. Retinal arteriolar diameter and risk for hypertension. Ann Intern Med 140 (2004) 248-255
3. Kwa V.I., van der Sande J.J., Stam J., et al., Amsterdam Vascular Medicine Group. Retinal arterial changes correlate with cerebral small-vessel disease. Neurology 59 (2002) 1536-1540
4. Nguyen T.T., and Wong T.Y. Retinal vascular manifestations of metabolic disorders. Trends Endocrinol Metab 17 (2006) 262-268
5. Goto I., Katsuki S., Ikui H., et al. Pathological studies on the intracerebral and retinal arteries in cerebrovascular and noncerebrovascular diseases. Stroke 6 (1975) 263-269
6. Smith D.O., and LeRoith D. Insulin resistance syndrome, pre-diabetes, and the prevention of type 2 diabetes mellitus. Clin Cornerstone 6 (2004) 7-13
7. Wong T.Y., Shankar A., Klein R., et al. Retinal arteriolar narrowing, hypertension, and subsequent risk of diabetes mellitus. Arch Intern Med 165 (2005) 1060-1065
8. Wong T.Y., Klein R., Sharrett A.R., et al., ARIC Investigators. Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons. JAMA 287 (2002) 2528-2533
9. Fulop T., Tessier D., and Carpentier A. The metabolic syndrome. Pathol Biol (Paris) 54 (2006) 375-386
10. Wang Y., and Beydoun M.A. The obesity epidemic in the United States-gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 29 (2007) 6-28
11. Lee I.M., Manson J.E., Hennekens C.H., and Paffenbarger Jr. R.S. Body weight and mortality: a 27-year follow-up of middle-aged men. JAMA 270 (1993) 2823-2828
12. Ikram M.K., de Jong F.J., Vingerling J.R., et al. Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders?. The Rotterdam Study. Invest Ophthalmol Vis Sci 45 (2004) 2129-2134
13. Ikram M.K., Witteman J.C., Vingerling J.R., et al. Retinal vessel diameters and risk of hypertension: the Rotterdam Study. Hypertension 47 (2006) 189-194
14. Liew G., and Wang J.J. Retinal vascular signs in diabetes and hypertension-review. Arq Bras Endocrinol Metabol 51 (2007) 352-362
15. Wong T.Y., Mosley Jr. T.H., Klein R., et al., Atherosclerosis Risk in Communities Study. Retinal microvascular changes and MRI signs of cerebral atrophy in healthy, middle-aged people. Neurology 61 (2003) 806-811
16. Leung H., Wang J.J., Rochtchina E., et al. Dyslipidaemia and microvascular disease in the retina. Eye 19 (2005) 861-868
17. van Leiden H.A., Dekker J.M., Moll A.C., et al. Blood pressure, lipids, and obesity are associated with retinopathy: the Hoorn study. Diabetes Care 25 (2002) 1320-1325
18. Klein R., Klein B.E., Knudtson M.D., et al. Are inflammatory factors related to retinal vessel caliber?. The Beaver Dam Eye Study. Arch Ophthalmol 124 (2006) 87-94
19. Singh U., Devaraj S., Vasquez-Vivar J., and Jialal I. C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling. J Mol Cell Cardiol 43 (2007) 780-791
20. Lagrand W.K., Visser C.A., Hermens W.T., et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?. Circulation 100 (1999) 96-102
21. Duncan B.B., Schmidt M.I., Pankow J.S., et al. Low-grade systemic inflammation and the development of type 2 diabetes: the Atherosclerosis Risk in Communities Study. Diabetes 52 (2003) 1799-1805
22. Wang J.J., Taylor B., Wong T.Y., et al. Retinal vessel diameters and obesity: a population-based study in older persons. Obesity (Silver Spring) 14 (2006) 206-214
23. Mather K.J., Hunt A.E., Steinberg H.O., et al. Repeatability characteristics of simple indices of insulin resistance: implications for research applications. J Clin Endocrinol Metab 86 (2001) 5457-5464
24. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
25. Radziuk J. Insulin sensitivity and its measurement: structural commonalities among the methods. J Clin Endocrinol Metab 85 (2000) 4426-4433
26. Knudtson M.D., Lee K.E., Hubbard L.D., et al. Revised formulas for summarizing retinal vessel diameters. Curr Eye Res 27 (2003) 143-149
27. Wong T.Y., Knudtson M.D., Klein R., et al. Computer-assisted measurement of retinal vessel diameters in the Beaver Dam Eye Study: methodology, correlation between eyes, and effect of refractive errors. Ophthalmology 111 (2004) 1183-1190
28. Hubbard L.D., Brothers R.J., King W.N., et al., Atherosclerosis Risk in Communities Study Group. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology 106 (1999) 2269-2280
29. Sharrett A.R., Hubbard L.D., Cooper L.S., et al. Retinal arteriolar diameters and elevated blood pressure: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 150 (1999) 263-270
30. Scheltens P., Barkhof F., Leys D., et al. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 114 (1993) 7-12
31. Shrout P.E., and Fleiss J.L. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86 (1979) 420-428
32. Kaushik S., Kifley A., Mitchell P., and Wang J.J. Age, blood pressure, and retinal vessel diameter: separate effects and interaction of blood pressure and age. Invest Ophthalmol Vis Sci 48 (2007) 557-561
33. Wong T.Y., Klein R., Sharrett A.R., et al., ARIC Investigators. Retinal arteriolar narrowing and risk of coronary heart disease in men and women: the Atherosclerosis Risk in Communities Study. JAMA 287 (2002) 1153-1159
34. Wong T.Y., Klein R., Klein B.E., et al. Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality. Surv Ophthalmol 46 (2001) 59-80
35. Mulvany M.J. Are vascular abnormalities a primary cause or secondary consequence of hypertension?. Hypertension 18 suppl (1991) I52-I57
36. Levy B.I., Ambrosio G., Pries A.R., and Struijker-Boudier H.A. Microcirculation in hypertension: a new target for treatment?. Circulation 104 (2001) 735-740
37. Caglayan E., Blaschke F., Takata Y., and Hsueh W.A. Metabolic syndrome-interdependence of the cardiovascular and metabolic pathways. Curr Opin Pharmacol 5 (2005) 135-142
38. Cusi K., Maezono K., Osman A., et al. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest 105 (2000) 311-320
39. Williams S.B., Cusco J.A., Roddy M.A., et al. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 27 (1996) 567-574
40. Nystrom T., Nygren A., and Sjoholm A. Increased levels of tumour necrosis factor-alpha (TNF-alpha) in patients with type II diabetes mellitus after myocardial infarction are related to endothelial dysfunction. Clin Sci (Lond) 110 (2006) 673-681
41. Zavaroni I., Ardigo D., Zuccarelli A., et al. Insulin resistance/compensatory hyperinsulinemia predict carotid intimal medial thickness in patients with essential hypertension. Nutr Metab Cardiovasc Dis 16 (2006) 22-27
42. Geroldi C., Frisoni G.B., Paolisso G., et al. Insulin resistance in cognitive impairment: the InCHIANTI Study. Arch Neurol 62 (2005) 1067-1072
43. Umegaki H., Kawamura T., Mogi N., et al. Glucose control levels, ischaemic brain lesions, and hyperinsulinaemia were associated with cognitive dysfunction in diabetic elderly. Age Ageing 37 (2008) 458-461
44. Convit A. Links between cognitive impairment in insulin resistance: an explanatory model. Neurobiol Aging 26 suppl (2005) 31-35
45. Ferrannini E., Natali A., Bell P., et al., European Group for the Study of Insulin Resistance (EGIR). Insulin resistance and hypersecretion in obesity. J Clin Invest 100 (1997) 1166-1173
46. Parikh N.I., Pencina M.J., Wang T.J., et al. Increasing trends in incidence of overweight and obesity over 5 decades. Am J Med 120 (2007) 242-250
47. Knudtson M.D., Klein B.E., Klein R., et al. Variation associated with measurement of retinal vessel diameters at different points in the pulse cycle. Br J Ophthalmol 88 (2004) 57-61
48. Klein R., Klein B.E., Tomany S.C., and Wong T.Y. The relation of retinal microvascular characteristics to age-related eye disease: the Beaver Dam Eye Study. Am J Ophthalmol 137 (2004) 435-444